Manyu XU, Yuan ZAHNG, Xu YI, et al. Exogenetic over-expression of pBDNF affects learning and memory in APPswePS1dE9 transgenic mice[J]. Journal of Third Military Medical University, 2021, 43(7): 629-634.
DOI:
Manyu XU, Yuan ZAHNG, Xu YI, et al. Exogenetic over-expression of pBDNF affects learning and memory in APPswePS1dE9 transgenic mice[J]. Journal of Third Military Medical University, 2021, 43(7): 629-634. DOI: 10.16016/j.1000-5404.202011150.
Exogenetic over-expression of pBDNF affects learning and memory in APPswePS1dE9 transgenic mice
To explore the effect and possible machanism of recombinant adeno-associated virus (rAAV) vector containing brain-derived neurotrophic factor propeptide (AAV-pBDNF) on learning and memory in APPswePS1dE9 transgenic mice (Alzheimer's disease
AD).
Methods
2
A total of 18 APPswePS1dE9 transgenic mice were randomly and equally divided into co
ntrol group
AAV-pBDNF group and AAV-pBDNF+p75NTR antibody group. Recombinant AAV-pBDNF vector (2 μL
1×10
12
vg/mL) were stereotaxically injected into the right side of the hippocampus in AAV-pBDNF group
AAV-GFP (2 μL
1×10
12
vg/mL) into that of the control group
and same amount of AAV-pBDNF and p75NTR antibody (2 μL
10 μg/mL) into that of the AAV-pBDNF+p75NTR antibody group. There were 6 mice in each group. Morris water maze test was performed in 4 weeks after hippocampal injection to detect the changes of learning and memory abilities in AD rats. Immunofluorescence assay was used to observe the transfection ofAAV-pBDNF in the brain. Western blotting was employed to measure the expression of postsynaptic density protein 95 (PSD-95) in the hippocampus.
Results
2
The results of Morris water maze showed that no significant difference was seen in the movement speed of each group (
P
>
0.05); the escape incubation period on day 5 in the control group and AAV-pBDNF+p75NTR antibody group was significantly shorter than that of day 1 (
P
<
0.05); similar result was seen in the pBDNF group though no statistical difference (
P
>
0.05); and less platforms were crossed in the AD mice of the pBDNF group than those in the other 2 groups on day 6 in space exploration experiment (
P
<
0.05). Immunofluorescence assay showed that after transfection
pBDNF was expressed in the neurons
but not glial cells in the hippocampus. Western blotting results indicated that the expression of PSD-95 was obviously lower in the AAV-pBDNF group than the other 2 groups (
P
<
0.05).
Conclusion
2
pBDNF inhibits the learning and memory abilities of AD mice by down-regulating hippocampal expression of PSD-95.
XU M Y, XU Z Q. Research progress on the relationship between different forms of brain-derived neurotrophic factors and Alzheimer's disease[J]. Chongqing Med, 2019, 48(6): 1025-1028.
JOE E, RINGMAN J M. Cognitive symptoms of Alzheimer's disease: clinical management and prevention[J]. BMJ Clin Res Ed, 2019, 367: l6217. DOI:10.1136/bmj.l6217.
FOLTRAN R B, DIAZ S L. BDNF isoforms: a round trip ticket between neurogenesis and serotonin?[J]. J Neurochem, 2016, 138(2): 204-221. DOI:10.1111/jnc.13658.
HARWARD S C, HEDRICK N G, HALL C E, et al. Autocrine BDNF-TrkB signalling within a single dendritic spine[J]. Nature, 2016, 538(7623): 99-103. DOI:10.1038/nature19766.
KUIPERS S D, TRENTANI A, TIRON A, et al. BDNF-induced LTP is associated with rapid Arc/Arg3.1-dependent enhancement in adult hippocampal neurogenesis[J]. Sci Rep, 2016, 6: 21222. DOI:10.1038/srep21222.
CHEN J, ZHANG T, JIAO S, et al. proBDNF accelerates brain amyloid-β deposition and learning and memory impairment in APPswePS1dE9 transgenic mice[J]. J Alzheimers Dis, 2017, 59(3): 941-949. DOI:10.3233/jad-161191.
CHEN J, LI C R, YANG H, et al. proBDNF attenuates hippocampal neurogenesis and induces learning and memory deficits in aged mice[J]. Neurotox Res, 2016, 29(1): 47-53. DOI:10.1007/s12640-015-9568-2.
LIM J Y, REIGHARD C P, CROWTHER D C. The pro-domains of neurotrophins, including BDNF, are linked to Alzheimer's disease through a toxic synergy with Aβ[J]. Hum Mol Genet, 2015, 24(14): 3929-3938. DOI:10.1093/hmg/ddv130.
GUO J, JI Y, DING Y, et al. BDNF pro-peptide regulates dendritic spines via caspase-3[J]. Cell Death Dis, 2016, 7: e2264. DOI:10.1038/cddis.2016.166.
XU M Y, CHEN J, XU Z Q. Effects of AAV-proBDNF on hippocampal DCX positive cells and PSD-95 expression in Alzheimer's disease mice[J]. J Third Mil Med Univ, 2019, 41(2): 95-99. DOI:10.16016/j.1000-5404.201808088.
ANASTASIA A, DEINHARDT K, CHAO M V, et al. Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction[J]. Nat Commun, 2013, 4: 2490. DOI:10.1038/ncomms3490.
HASHIMOTO K. Regulation of brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain by serotonin[J]. Eur Arch Psychiatry Clin Neurosci, 2016, 266(3): 195-197. DOI:10.1007/s00406-016-0682-9.
ZANIN J P, UNSAIN N, ANASTASIA A. Growth factors and hormones pro-peptides: the unexpected adventures of the BDNF prodomain[J]. J Neurochem, 2017, 141(3): 330-340. DOI:10.1111/jnc.13993.
KOJIMA M, MATSUI K, MIZUI T. BDNF pro-peptide: physiological mechanisms and implications for depression[J]. Cell Tissue Res, 2019, 377(1): 73-79. DOI:10.1007/s00441-019-03034-6.
MIZUI T, HATTORI K, ISHIWATA S, et al. Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia[J]. J Psychiatr Res, 2019, 113: 190-198. DOI:10.1016/j.jpsychires.2019.03.024.
GIZA J I, KIM J, MEYER H C, et al. The BDNF Val66Met prodomain disassembles dendritic spines altering fear extinction circuitry and behavior[J]. Neuron, 2018, 99(1): 163-178. e6. DOI:10.1016/j.neuron.2018.05.024.
YANG B, REN Q, ZHANG J C, et al. Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis[J]. Transl Psychiatry, 2017, 7(5): e1128. DOI:10.1038/tp.2017.95.
LISEK M, FERENC B, STUDZIAN M, et al. Glutamate deregulation in ketamine-induced psychosis-A potential role of PSD95, NMDA receptor and PMCA interaction[J]. Front Cell Neurosci, 2017, 11: 181. DOI:10.3389/fncel.2017.00181.
HORGUSLUOGLU-MOLOCH E, NHO K, RISACHER S L, et al. Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease[J]. Neurobiol Aging, 2017, 60: 92-103. DOI:10.1016/j.neurobiolaging.2017.08.010.
Effects of hippocampal aromatase overexpression on spatial learning and memory in APP/PS1 mouse model of Alzheimer’s disease and related neural mechanism
Effect of repeated transcranial direct current stimulation on learning and memory ability in rat models of Alzheimer’s disease
Differentiation and therapeutic effects of C17.2 neural stem cells after transplanted into hippocampus of Aβ1-40 injuried rats
Deep Cervical Lymphatic-Venous Anastomosis for Alzheimer Disease: A Case Series Report
Molecular mechanism of circ-Tns3/miR-671-5p/sirt1 axis mediating neuronal damage in Alzheimer’s disease
Related Author
孟召友
孙欢
兰震
连碧瑶
蔡晓霞
刘志
王祥
张吉强
Related Institution
Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University